Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force
- PMID: 34174130
- PMCID: PMC9290926
- DOI: 10.1111/bdi.13105
Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force
Abstract
Objectives: Clinical staging is widely used in medicine to map disease progression, inform prognosis, and guide treatment decisions; in psychiatry, however, staging remains a hypothetical construct. To facilitate future research in bipolar disorders (BD), a well-defined nomenclature is needed, especially since diagnosis is often imprecise with blurred boundaries, and a full understanding of pathophysiology is lacking.
Methods: Under the auspices of the International Society of Bipolar Disorders, a Task Force of international experts was convened to review, discuss, and integrate findings from the scientific literature relevant to the development of a consensus staging model and standardize a terminology that could be used to advance future research including staging of BD and related disorders.
Results: Consensus opinion and areas of uncertainty or difference were identified in regard to terms referring to staging as it may apply to BD, to at-risk status and subthreshold stages, and to various clinical stages of BD as it is currently diagnosed.
Conclusion: The use of a standardized nomenclature about the clinical stages of BD will facilitate communication about research on clinical and pathological components of this heterogeneous group of disorders. The concepts presented are based on current evidence, but the template provided allows for further refinements as etiological advances come to light.
Keywords: bipolar disorders; clinical staging; nomenclature.
© 2021 The Authors. Bipolar Disorders published by John Wiley & Sons Ltd.
Similar articles
-
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.Bipolar Disord. 2009 Aug;11(5):453-73. doi: 10.1111/j.1399-5618.2009.00726.x. Bipolar Disord. 2009. PMID: 19624385 Review.
-
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.Am J Psychiatry. 2013 Nov;170(11):1249-62. doi: 10.1176/appi.ajp.2013.13020185. Am J Psychiatry. 2013. PMID: 24030475 Free PMC article.
-
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.Bipolar Disord. 2017 Dec;19(8):614-626. doi: 10.1111/bdi.12534. Epub 2017 Sep 12. Bipolar Disord. 2017. PMID: 28895274 Free PMC article.
-
Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force.Bipolar Disord. 2019 Nov;21(7):582-594. doi: 10.1111/bdi.12828. Epub 2019 Sep 18. Bipolar Disord. 2019. PMID: 31465619 Review.
-
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report.Acta Psychiatr Scand. 2014 Nov;130(5):354-63. doi: 10.1111/acps.12305. Epub 2014 Jun 25. Acta Psychiatr Scand. 2014. PMID: 24961757 Review.
Cited by
-
Heterogeneous early illness courses of Korean patients with bipolar disorders: replication of the staging model.BMC Psychiatry. 2022 Nov 4;22(1):684. doi: 10.1186/s12888-022-04318-y. BMC Psychiatry. 2022. PMID: 36333702 Free PMC article.
-
Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review.Pharmaceutics. 2022 Dec 1;14(12):2674. doi: 10.3390/pharmaceutics14122674. Pharmaceutics. 2022. PMID: 36559168 Free PMC article. Review.
-
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.World Psychiatry. 2022 Oct;21(3):364-387. doi: 10.1002/wps.20997. World Psychiatry. 2022. PMID: 36073706 Free PMC article.
-
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders.Brain Behav Immun Health. 2025 Feb 13;44:100962. doi: 10.1016/j.bbih.2025.100962. eCollection 2025 Mar. Brain Behav Immun Health. 2025. PMID: 40046177 Free PMC article.
-
Gordon Parker: Staging the bipolar disorders: Are early stages at too early a stage for intervention?Bipolar Disord. 2022 Dec;24(8):828-829. doi: 10.1111/bdi.13278. Epub 2022 Dec 1. Bipolar Disord. 2022. PMID: 36433661 Free PMC article. No abstract available.
References
-
- Gospodarowicz MK, Wittekind C, Brierley JD. eds. TNM classification of malignant tumors, 8th edn. Wiley & Sons; 2016.
-
- Scott S, Henry C. Clinical staging models: from general medicine to mental disorders. BJPsych Advances. 2017;23:292‐299.
-
- Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res. 2011;19(2):279‐285. - PubMed
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Association; 2013.
-
- World Health Organization . (2019). International Statistical Classification of Diseases and Related Health Problems (11th ed.; ICD‐11).